Is antifungal susceptibility testing useful in guiding fluconazole therapy?

Clinical Infectious Diseases

Volumn 22, Issue SUPPL. 2, 1996, Pages

  Ghannoum, Mahmoud A ^a,b  

^a St John's Cardiovascular Research Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; CANDIDIASIS; CONFERENCE PAPER; DIAGNOSTIC VALUE; DRUG EFFICACY; FUNGAL MENINGITIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; PREDICTION; PRIORITY JOURNAL; STANDARD; TREATMENT OUTCOME;

EID: 0030017219     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.supplement_2.s161     Document Type: Conference Paper

References (25)

1. Anaissie EJ, Bodey GP, Rinaldi MG. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis 1989;8:323-30.
2. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86S-9S.
3. Wenzel RP, Pfaller MA. Candida species: emerging hospital bloodstream pathogens [editorial]. Infect Control Hosp Epidemiol 1991;12:523-4.
4. Sanguineti A, Carmichael JK, Campbell K. Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med 1993;153:1122-4.
5. Smith KJ, Warnock DW, Kennedy CTC, et al. Azole resistance in Candida albicans. J Med Vet Mycol 1986;24:133-44.
6. Warnock DW, Burke J, Cope NJ, Johnson EM, von Fraunhoffer NA, Williams EW. Fluconazole resistance in Candida glabrata [letter]. Lancet 1988;2:1310.
7. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
8. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard. NCCLS document M27-P. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1992.
9. Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG. Multicenter evaluation of four methods of yeast inoculum preparation. J Clin Microbiol 1988;26:1437-41.
10. Pfaller MA, Rinaldi MG, Galgiani JN, et al. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother 1990;34:1648-54.
11. Ghannoum MA, Ibrahim AS, Fu Y, Shafiq MC, Edwards JE Jr, Criddle RS. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol 1992;30:2881-6.
12. Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN. Antifungal susceptibility testing. Clin Microbiol Rev 1993;6:367-81.
13. Willocks L, Leen CLS, Brettle RP, Urquhart D, Russell TB, Milne LJR. Fluconazole resistance in AIDS patients [letter]. J Antimicrob Agents Chemother 1991;28:937-9.
14. Dupont B, Improvisi L, Eliaszewicz M, Pialoux G, the GEMO. Resistance of Candida albicans to fluconazole (FCZ) in AIDS patients [abstract no 1203]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society for Microbiology, 1992.
15. Rodriguez-Tudela JL, Laguna F, Martinez-Suarez JV, Chaves F, Dronda F, CIC. Fluconazole resistance of Candida albicans isolates from AIDS patients receiving prolonged antifungal therapy [abstract no 1204]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society for Microbiology, 1992.
16. Troillet N, Durussel C, Bille J, Glauser MP, Chave JP. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993;12:911-5.
17. Sandven P, Bjorneklett A, Maeland A, the Norwegian Yeast Study Group. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. Antimicrob Agents Chemother 1993;37: 2443-8.
18. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994;18:240-2.
19. Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994;97:339-46.
20. Pfaller MA, Rhine-Chalberg J, Redding SW, et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994;32:59-64.
21. Barchiesi F, Colombo AL, McGough DA, Rinaldi MG. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. J Clin Microbiol 1994;32:2494-500.
22. Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD for the NIAID Mycoses Study Group and the Candidemia Study Group. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 1995;39:40-4.
23. Goff DA, Koletar SL, Buesching WJ, Barnishan J, Fass RJ. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin Infect Dis 1995;20:77-83.
24. Sheehan DJ, Espinel-Ingroff A, Moore LS, Webb CD. Antifungal susceptibility testing of yeasts: a brief overview. Clin Infect Dis 1993;17(suppl 2):S494-500.
25. Witt MD, Lewis RJ, Larsen RA, et al. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 1996;22:322-8.